Gadolinium Toxicity Lawsuits
Lawsuits have been filed against the manufacturers of Gadolinium-Based Contrast Agents (GBCA). These lawsuits claim that manufactures failed to warn healthcare providers of the dangers associated with the use of GBCAs and the potential for gadolinium retention in the body. There is evidence that GBCAs instead of being passed are being retained by various parts of the body. Patients who have undergone an MRI or MRA with the use of linear gadolinium-based contrast agents can suffer from severe injuries and side effects associated with Gadolinium Toxicity. Gadolinium Toxicity has been linked to several medical conditions such as Nephrogenic Systemic Fibrosis, Gadolinium Deposition Disease and Gadolinium Storage Condition.